OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis
Innocent G. Asiimwe, Sudeep Pushpakom, Richard M. Turner, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 12, pp. 4534-4545
Open Access | Times Cited: 17

Showing 17 citing articles:

Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis
Mochamad Yusuf Alsagaff, Eka Prasetya Budi Mulia, Irma Maghfirah, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 5, pp. 102210-102210
Open Access | Times Cited: 30

Cardiac Manifestations in Patients with COVID-19: A Scoping Review
Sasha Peiris, Pedro Ordúñez, Donald J. DiPette, et al.
Global Heart (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 17

Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis
Shaodi Ma, Wanying Su, Chenyu Sun, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 9, pp. 1403-1420
Open Access | Times Cited: 17

An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
Amanj Kurdi, Tanja Mueller, Natalie Weir
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 2
Open Access | Times Cited: 12

Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, et al.
Revista Portuguesa de Cardiologia (2023) Vol. 42, Iss. 4, pp. 373-383
Open Access | Times Cited: 7

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
Innocent G. Asiimwe, Sudeep Pushpakom, Richard M. Turner, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 8, pp. 3577-3599
Open Access | Times Cited: 10

Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology
Grammati Sarri, Wei Liu, Luke E. Zabotka, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 3, pp. 604-613
Open Access | Times Cited: 5

Methodological quality and reporting quality of COVID-19 living systematic review: a cross-sectional study
Jiefeng Luo, Zhe Chen, Dan Liu, et al.
BMC Medical Research Methodology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5

SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies
Mary G. Hornick, Margaret E. Olson, Arun L. Jadhav
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 1-12
Open Access | Times Cited: 13

Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with meta-analysis and trial sequential analysis
Hong Duo, Mengying Jin, Yanwei Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0297628-e0297628
Open Access | Times Cited: 1

Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?
A. Gabet, Clémence Grave, Philippe Tuppin, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 6

Impact of COVID-19 Pandemic on Dispensing of Cardiovascular Drugs in Norway: An Interrupted Time Series Study
Ugochinyere Vivian Ukah, Robert W. Platt, Hedvig Nordeng
American Journal of Preventive Medicine (2023) Vol. 66, Iss. 4, pp. 672-680
Open Access | Times Cited: 2

Characteristics of Living Systematic Review for COVID-19
Zhe Chen, Jiefeng Luo, Siyu Li, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 925-935
Open Access | Times Cited: 3

Effects of previous exposure to different medications on clinical course of COVID-19 patients in Istanbul, Turkey
Ülkü Sur Ünal, Hasan Raci Yananlı, Ömer Kays Ünal, et al.
Authorea (Authorea) (2024)
Open Access

Effects of previous exposure to different medications on the clinical course of COVID-19 patients in Istanbul, Turkey
Ülkü Sur Ünal, Hasan Raci Yananlı, Ömer Kays Ünal, et al.
Journal of Surgery and Medicine (2023) Vol. 7, Iss. 1, pp. 79-85
Open Access

Genetic factors associated with tuberculosis-related clinical outcomes in HIV-infected Black African patients: a systematic review and meta-analysis
Innocent G. Asiimwe, Daniel Kiiza, Stephen Walimbwa, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 15, pp. 997-1017
Open Access

Page 1

Scroll to top